Barry et al24 found that dendritic cells (DC)—NK interactions in tumor microenvironment are potentially prognostic in anti‐PD‐1 immunotherapy and that T‐cell antitumor responses are dependent on these innate immune cells. The gene discussed is PDCD1; the disease is neoplasm.